Codice QR

Maintenance therapy in multiple myeloma

Salvato in:

Dettagli Bibliografici
Autore principale:	Harousseau, Jean-Luc
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	PAGEPress Publications 2009
Soggetti:	Article
Accesso online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3222249/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2009.e12
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi

Multiple Myeloma: Biology, Standard Therapy, and Transplant Therapy
di: Gertz, Morie A., et al.
Pubblicazione: (2009)

Maintenance therapy in multiple myeloma
di: Mewawalla, Prerna, et al.
Pubblicazione: (2016)

Maintenance therapies for multiple myeloma
di: Mahony, Helen, et al.
Pubblicazione: (2016)

The role of maintenance therapy in multiple myeloma
di: Lipe, B, et al.
Pubblicazione: (2016)

Next-generation multiple myeloma treatment: a pharmacoeconomic perspective
di: Rajkumar, S. Vincent, et al.
Pubblicazione: (2016)

IMWG consensus on maintenance therapy in multiple myeloma
di: Ludwig, Heinz, et al.
Pubblicazione: (2012)

Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
di: Mohty, Mohamad, et al.
Pubblicazione: (2014)

Posttransplant maintenance therapy in multiple myeloma: the changing landscape
di: Sengsayadeth, S, et al.
Pubblicazione: (2017)

Extrapyramidal Symptoms with Administration of Lenalidomide Maintenance Therapy for Multiple Myeloma
di: Sagar, FNU, et al.
Pubblicazione: (2018)

Current status of autologous stem cell transplantation for multiple myeloma
di: Al Hamed, Rama, et al.
Pubblicazione: (2019)

Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
di: Lee, Ho Sup, et al.
Pubblicazione: (2016)

Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma
di: Alonso, Rafael, et al.
Pubblicazione: (2020)

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations
di: Mohty, Bilal, et al.
Pubblicazione: (2010)

Emerging therapies for multiple myeloma
di: Podar, Klaus, et al.
Pubblicazione: (2009)

Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
di: Zhang, Shijia, et al.
Pubblicazione: (2020)

Proteasome inhibitors in multiple myeloma: 10 years later
di: Moreau, Philippe, et al.
Pubblicazione: (2012)

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
di: Cornell, Robert F., et al.
Pubblicazione: (2016)

Lenalidomide in the Treatment of Young Patients with Multiple Myeloma: From Induction to Consolidation/Maintenance Therapy
di: Lupo, Barbara, et al.
Pubblicazione: (2012)

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
di: Dimopoulos, Meletios A., et al.
Pubblicazione: (2020)

Role of Maintenance Therapy After Autologous Stem Cell Transplant for Multiple Myeloma: Lessons for Cancer Therapy
di: Kyle, Robert A.
Pubblicazione: (2011)

Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review
di: Wang, Yucai, et al.
Pubblicazione: (2015)

Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
di: Avet-Loiseau, Hervé, et al.
Pubblicazione: (2009)

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b.
di: Bell, J. B., et al.
Pubblicazione: (1994)

Modern therapy of multiple myeloma
di: O. M. Votyakova
Pubblicazione: (2008-12-01)

New therapies in multiple myeloma
di: Merchionne, F., et al.
Pubblicazione: (2007)

Multitargeted therapies for multiple myeloma
di: Kharaziha, Pedram, et al.
Pubblicazione: (2013)

Diagnosis and therapy of multiple myeloma
di: Palumbo, Antonio, et al.
Pubblicazione: (2013)

Promising therapies in multiple myeloma
di: Bianchi, Giada, et al.
Pubblicazione: (2015)

Novel therapies for multiple myeloma
di: Wallington-Beddoe, Craig T., et al.
Pubblicazione: (2017)

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
di: Stadtmauer, Edward A., et al.
Pubblicazione: (2019)

Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma
di: Dejoie, Thomas, et al.
Pubblicazione: (2016)

Letter: Maintenance therapy in myeloma: risk versus benefit.
di: Sieber, S M, et al.
Pubblicazione: (1975)

Letter: Maintenance therapy in myeloma: rish versus benefit.
di: Jacobs, P, et al.
Pubblicazione: (1975)

Bortezomib Combination Therapy in Multiple Myeloma
di: Kapoor, Prashant, et al.
Pubblicazione: (2012)

Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma
di: Sborov, Douglas W., et al.
Pubblicazione: (2015)

Antibody-Based Therapies in Multiple Myeloma
di: Tai, Yu-Tzu, et al.
Pubblicazione: (2011)

Molecularly Targeted Therapies in Multiple Myeloma
di: de la Puente, Pilar, et al.
Pubblicazione: (2014)

O papel da terapia de manutenção no Mieloma Múltiplo The role of maintenance therapy for Multiple Myeloma
di: Rosane Bittencourt
Pubblicazione: (2007-03-01)

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
di: Jagannath, Sundar, et al.
Pubblicazione: (2018)

Ixazomib–Thalidomide–Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
di: Ludwig, Heinz, et al.
Pubblicazione: (2019)